Fig. 1 · Structure

Documents & Downloads

Tadalafil

Cat. No. A10883 CAS 171596-29-5

PDE5 inhibitor

Tadalafil is a PDE5 inhibitor with an IC50 value of 1.8 nM.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
PDE5 (Cell-free assay) 1.8 nM

Tadalafil Research Summary

This section summarizes 3 in vitro studies and 1 in vivo study of Tadalafil from 3 published references. In vitro models include primary cultured mouse MSNs. In vivo models include C57BL/6J syngeneic mice.

Tadalafil In Vitro Studies

In primary cultured mouse MSNs with PDE5A overexpression, Tadalafil could rescue decreased dendritic complexity, whereas DMSO did not. In the same model, Tadalafil could prevent apoptosis and restore it to a level similar to control, whereas DMSO did not prevent apoptosis. In primary hippocampal neuronal cultures from embryonic wild-type mice, Tadalafil had no effect on the measured histone acetylation readout. [1,2]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Tadalafil and dendritic complexity in cultured mouse neurons

Cell-based study · primary cultured mouse MSNs [1]

In primary cultured mouse MSNs with PDE5A overexpression, Tadalafil could rescue decreased dendritic complexity compared with the DMSO-treated overexpression group. Vehicle did not rescue dendritic complexity.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
dendritic complexityReported result tadalafil treatment could rescue the decreased dendritic complexity caused by PDE5A overexpression while vehicle did not[1]

Literature-Reported Treatment Conditions

Treatment concentration
10 μM
Exposure duration
at DIV7 and DIV10 for 12 h
Vehicle
DMSO
Co-treatment
Other interventions in this design: rAAV2/9-hSyn-PDE5A-EGFP. Compound effect isolated by the comparison: OE+tadalafil and OE + DMSO.
Reported limits
Not stated in the sentences used: route.
Methods and source locations

Compound reported in the paper: Tadalafil

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Results > Overexpression of PDE5A in primary mouse striatal neurons led to reduced dendrite complexity, elevated apoptosis, and increased neuronal excitability and membrane resistance (S104, S106, S109); Methods > Primary MSN culture and adeno-associated virus (AAV) infection (S249, S250, S251); Fig. 5 legend (S385)

dendritic complexity: dendritic complexity; comparator: OE + DMSO — Results > Overexpression of PDE5A in primary mouse striatal neurons led to reduced dendrite complexity, elevated apoptosis, and increased neuronal excitability and membrane resistance (S106)

Tadalafil and histone acetylation in primary hippocampal cultures

Cell-based study · Primary neuronal cultures were obtained from the hippocampus of embryonic day 16 (E16) wild-type (WT) mice and used at 15 days in vitro (DIV) [2]

Primary hippocampal neuronal cultures from embryonic wild-type mice were treated with Tadalafil and compared with vehicle-treated cultures. Tadalafil had no effect on the measured histone acetylation readout.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
histone 3 acetylation at lys9 (AcH3K9)Reported result no effect was found with tadalafil[2]

Literature-Reported Treatment Conditions

Treatment concentration
10, 100 and 500 nM
Exposure duration
2 h
Method
Cultures were treated
Vehicle
DMSO
Methods and source locations

Compound reported in the paper: Tadalafil

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Results > The concomitant inhibition of HDAC and PDE5 has a synergistic effect on histone acetylation (S1, S2, S10); Methods > Drugs (S73); Methods > Primary neuronal cultures and treatments (S76, S77)

histone 3 acetylation at lys9 (AcH3K9): histone 3 acetylation at lys9 (AcH3K9); comparator: control vehicle-treated cultures — Results > The concomitant inhibition of HDAC and PDE5 has a synergistic effect on histone acetylation (S1, S2)

Tadalafil and apoptosis in cultured mouse neurons

Cell-based study · primary cultured mouse MSNs [1]

In primary cultured mouse MSNs with PDE5A overexpression, Tadalafil could prevent apoptosis compared with the DMSO-treated overexpression group, restoring it to a level similar to control. DMSO treatment did not prevent apoptosis.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
ratio of caspase 3+GFP+ cells in GFP+ cellsReported result Tadalafil but not DMSO treatment could prevent OE neurons from apoptosis, recovering to a level similar as that of control group[1]

Literature-Reported Treatment Conditions

Treatment concentration
10 μM
Exposure duration
at DIV7 and DIV10 for 12 h
Vehicle
DMSO
Co-treatment
Other interventions in this design: rAAV2/9-hSyn-PDE5A-EGFP. Compound effect isolated by the comparison: OE+tadalafil and OE + DMSO.
Reported limits
Not stated in the sentences used: route.
Methods and source locations

Compound reported in the paper: Tadalafil

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Results > Overexpression of PDE5A in primary mouse striatal neurons led to reduced dendrite complexity, elevated apoptosis, and increased neuronal excitability and membrane resistance (S119, S121); Methods > Primary MSN culture and adeno-associated virus (AAV) infection (S249, S250, S251); Methods > Immunofluorescence staining and analysis of dendritic morphology (S262); Fig. 5 legend (S385)

ratio of caspase 3+GFP+ cells in GFP+ cells: ratio of caspase 3+GFP+ cells in GFP+ cells; comparator: OE + DMSO — Results > Overexpression of PDE5A in primary mouse striatal neurons led to reduced dendrite complexity, elevated apoptosis, and increased neuronal excitability and membrane resistance (S119, S121)

Tadalafil In Vivo Studies

In syngeneic mice, intraperitoneal Tadalafil was compared with vehicle for antitumor efficacy. Tumors did not respond to single-agent therapies. [3]

Antitumor efficacy in syngeneic mice

Animal study · C57BL/6J syngeneic mice [3]

In syngeneic mice, intraperitoneal Tadalafil was compared with vehicle for antitumor efficacy. Tumors did not respond to single-agent therapies.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
antitumor efficacyReported result tumors did not respond to single-agent therapies[3]

Conditions shared by the study groups

Route
intraperitoneally
Treatment course
3 times per week
Vehicle
dissolved in DMSO at 20 mg/mL, resuspended with cremophor at 20 mg/mL, and resuspended with 1× PBS
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Tadalafil 2 mg/kgvehicletumors did not respond to single-agent therapies[3]
Tadalafil 2 mg/kg
Model: C57BL/6J syngeneic mice
Methods and source locations

Compound reported in the paper: Tadalafil

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Results > PDE5 inhibition synergizes with immunotherapies to shift myeloid and lymphoid compartments toward pro-inflammatory states and reduce tumor growth in PDAC mouse models. (S10, S11, S12); Methods > Cell lines and animal models. (S133, S134, S135, S137)

antitumor efficacy: antitumor efficacy; comparator: vehicle — Results > PDE5 inhibition synergizes with immunotherapies to shift myeloid and lymphoid compartments toward pro-inflammatory states and reduce tumor growth in PDAC mouse models. (S12)

Tadalafil 2 mg/kg · Results > PDE5 inhibition synergizes with immunotherapies to shift myeloid and lymphoid compartments toward pro-inflammatory states and reduce tumor growth in PDAC mouse models. (S11, S12); Methods > Cell lines and animal models. (S135)

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 171596-29-5
Applications PDE5 inhibitor
Formula C22H19N3O4
Molecular Weight 389.4
Synonyms Adcirca; Cialis
SMILES
CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 70 mg/mL (179.76 mM)
Water Insoluble
Ethanol Insoluble

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

In Vivo Preparation

Concentration
28 mg/mL
Vehicle
30% propylene glycol, 5% Tween 80, 65% D5W

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Tadalafil Research References

  1. [1] Bai Z, Li P, Gao X, et al. Exploring PDE5A upregulation in bipolar disorder: insights from single-nucleus RNA sequencing of human basal ganglia. Transl Psychiatry (2024). PMID: 39695100 DOI: 10.1038/s41398-024-03202-5 Source material
  2. [2] Cuadrado-Tejedor M, Garcia-Barroso C, Sanzhez-Arias J, et al. Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer's disease. Clin Epigenetics (2015). PMID: 26457123 DOI: 10.1186/s13148-015-0142-9 Source material
  3. [3] Gross NE, Zhang Z, Mitchell JT, et al. Phosphodiesterase-5 inhibition collaborates with vaccine-based immunotherapy to reprogram myeloid cells in pancreatic ductal adenocarcinoma. JCI Insight (2024). PMID: 39106104 DOI: 10.1172/jci.insight.179292 Source material

Added to your cart

View Cart Checkout
Loading...